Retatrutide is not yet FDA approved, unlike many GLP-1 agonists, retatrutide will most likely be a weekly injection, delivered subcutaneously into the arm, thigh or stomach area in a self-inject pen
It covers how GLP-1 medications work, what to realistically expect in the first months, how to manage side effects, and answers to the questions patients ask most
Tiago Meneses24 May 2026 Working well
Although they are both weight loss drugs powered by similar mechanisms influencing appetite regulation but they are not exactly the same
Labs are recommended but not required
We can help determine if an underlying health conditionsuch as polycystic ovary syndrome (PCOS), thyroid disorders, or another hormonal imbalancemay be contributing to these changes